-
Signature
-
/s/ Katherine A. Krebel, Attorney-in-Fact
-
Stock symbol
-
DRS
-
Transactions as of
-
Nov 29, 2024
-
Transactions value $
-
-$786,142
-
Form type
-
4
-
Date filed
-
12/3/2024, 05:56 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
DRS |
Common Stock |
Options Exercise |
$0 |
+17.1K |
+260.14% |
$0.00 |
23.7K |
Nov 29, 2024 |
Direct |
F1 |
transaction |
DRS |
Common Stock |
Tax liability |
-$213K |
-6.13K |
-25.81% |
$34.77 |
17.6K |
Nov 29, 2024 |
Direct |
F2 |
transaction |
DRS |
Common Stock |
Options Exercise |
$0 |
+11.4K |
+64.91% |
$0.00 |
29K |
Nov 29, 2024 |
Direct |
F3 |
transaction |
DRS |
Common Stock |
Tax liability |
-$187K |
-5.37K |
-18.5% |
$34.77 |
23.7K |
Nov 29, 2024 |
Direct |
F2 |
transaction |
DRS |
Common Stock |
Sale |
-$386K |
-11.1K |
-46.9% |
$34.81 |
12.6K |
Dec 2, 2024 |
Direct |
F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
DRS |
Performance Restricted Stock Unit |
Options Exercise |
$0 |
-17.1K |
-100% |
$0.00 |
0 |
Nov 29, 2024 |
Common Stock |
17.1K |
|
Direct |
F1 |
transaction |
DRS |
Restricted Stock Unit |
Options Exercise |
$0 |
-11.4K |
-100% |
$0.00 |
0 |
Nov 29, 2024 |
Common Stock |
11.4K |
|
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: